Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Spring-fall flu shots safe, protect children


Giving flu vaccine to toddlers in the spring and fall guards against infection and is easier on parents than the fall schedule of two doses administered a month apart, found researchers from Duke University Medical Center and the University of Washington.

The study compared the immune response in toddlers aged six to 23 months who received a flu shot in the spring and one in the fall, to the response of those who received fall shots separated by one month. The Centers for Disease Control and Prevention this year issued a recommendation for flu vaccination for all children in this age group. Children given spring-fall shots – up to six months apart – were as well-protected as those who received two shots in the fall, the study showed. The spring-fall group also completed their immunization earlier than toddlers in the fall group. A survey of parents showed 66 percent preferred the spring-fall schedule.

The results were presented Oct. 2, 2004, at the annual meeting of the Infectious Diseases Society of America. The study was sponsored by an unrestricted grant from Aventis Pasteur, which manufactures flu vaccine. "Kids less than two years old have a higher risk of significant complications from flu that require hospitalization. Trying to get them all in for their shots in fall is logistically tough and not necessarily convenient for parents. If we can get more kids immunized by making the schedule more convenient for parents, then we’ll prevent more severe flu complications," said Emmanuel Walter, M.D., associate professor of pediatrics at Duke University Medical Center.

In the trial, the spring dose given during the study was the 2002-2003 vaccine and the fall dose was the 2003-2004 vaccine. Both vaccines coincidently had similar antigen components. Antigens are substances that stimulate an immune response. This year, the researchers will compare the immune protection afforded by the spring-fall schedule when the inactivated flu vaccine changes significantly from year to year. Toddlers enrolled in the study this spring received the 2003-2004 vaccine and will receive the 2004-2005 vaccine this fall. "I don’t want practitioners to adopt this until the study is complete because we have not tested this schedule when the vaccine antigens changed from year to year. The key result will be what happens this year when the antigens change," Walter said.

The CDC recommends that children younger than nine years old should receive two doses of inactivated flu vaccine if not previously vaccinated, because they do not develop a strong immune response to a single dose. Physicians are advised to administer the two shots one month apart. This dosing schedule strains the capacity of primary care centers and may delay full vaccination for children until flu season is already underway, Walter said.

Children in the standard fall group completed their immunizations two months later than the spring-fall group during the study. Ninety-five percent of children in the spring-fall group received two doses by Oct. 2, while 95 percent of those in the standard group finished two doses by Dec. 2.

Vaccinating children less than two years old is especially important because they are more likely to develop flu complications requiring hospitalization. For example, gastrointestinal symptoms such as nausea, vomiting and diarrhea are much more common in children than adults. Children are also contagious longer than adults, shedding virus for more than a week. "This new schedule could potentially increase rates of influenza immunization in young children, a group at high risk for complications of influenza," said Janet Englund, M.D., associate professor of pediatrics at the University of Washington and Children’s Hospital and Regional Medical Center.

Closely-spaced clinic visits can also be inconvenient for parents. A survey of parents who participated in the study found 66 percent preferred the spring-fall schedule to the standard schedule. Eight percent had no preference, and 26 percent preferred the standard two doses in fall. "Providing influenza vaccine to children at the same time as other childhood vaccines on a spring-fall schedule was preferred by parents and decreased their number of office visits," Englund said.

The study also examined flu vaccine safety in young children. There were no severe adverse events associated with the vaccine during the study. The most common side effects were irritability, sleep change, low grade fever and pain and tenderness at the injection site. There were no differences in side effects between the spring-fall group and the standard fall dose group of toddlers. "This suggests the vaccine is pretty well-tolerated in this age group," Walters said.

Co-authors on the study include Mary Fairchok, M.D. of the Madigan Army Medical Center in Tacoma, Wash.; Kathleen Neuzil, M.D., University of Washington; and Arnold Monto, M.D., University of Michigan.

Becky Oskin | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Scientists develop tiny tooth-mounted sensors that can track what you eat
22.03.2018 | Tufts University

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Modular safety concept increases flexibility in plant conversion

22.03.2018 | Trade Fair News

New interactive map shows climate change everywhere in world

22.03.2018 | Earth Sciences

New technologies and computing power to help strengthen population data

22.03.2018 | Earth Sciences

Science & Research
Overview of more VideoLinks >>>